A Cost-Per-Responder Analysis of Secukinumab Compared with Ustekinumab in Saudi Arabia- Results from the Clear Study of Patients With Moderate to Severe Psoriasis
Abstract
Authors
M Al Howimel K Al Jufan A AlAlwan N Alshehri H Al Mudaiheem A Al Amri H Al Hamdan N Zakaria L Al Kateb I Gilloteau CN Graham M Sekharan